Alkem Laboratories (ALKEM) Share Price falls 2.26% as stock trades at Rs 5,377.50
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Alkem Laboratories Share Price fell to Rs 5,377.50 on 21 September 2026, down 2.26% from the previous close, and the company’s market capitalisation stood at Rs 65,779.88 crore. The move places Alkem Laboratories in focus in today’s stock news because the decline happened without any company-specific trigger being established by the supplied data. The session therefore needs to be read through the numbers alone: current price, the day’s range, turnover and valuation all provide the verified context for Alkem Laboratories Share Price Today. In this Univest analysis, the share price fall is treated as a factual market event, followed by a closer look at fundamentals, sector comparison and peer positioning. For readers tracking Alkem Laboratories Share Price Today, the important question is not only what changed in the quote, but what the broader data says about the stock’s standing in healthcare.
Alkem Laboratories (ALKEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,377.5 |
| Previous Close | Rs 5,501.6 |
| Today's Move | -Rs 124.10 (-2.26%) |
| Open | Rs 5,409.8 |
| High | Rs 5,409.8 |
| Low | Rs 5,340.65 |
| Turnover | Rs 0.59 crore |
| Market Capitalisation | Rs 65,779.88 crore |
| Market Cap Category | Large Cap |
Alkem Laboratories Share Price Today opened at Rs 5,409.80, matched the day high at Rs 5,409.80 and touched a low of Rs 5,340.65 before closing at Rs 5,377.50. That compares with the previous close of Rs 5,501.60, which means the stock fell Rs 124.10 in a single session. The day’s decline of 2.26% is a clear price fall for the session, while turnover stood at Rs 0.59 crore. The market-cap category supplied for the company is Large Cap, and the market capitalisation was Rs 65,779.88 crore. On a price-only basis, the session shows a lower close than the previous day, with the intraday range remaining relatively contained around the opening level. For readers of Alkem Laboratories Stock News, the essential point is that the supplied data confirms the fall but does not establish a company-specific catalyst. That makes the next step a review of the stock’s fundamental context and valuation within healthcare.
Alkem Laboratories (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 65,779.88 crore |
| P/E Ratio | 30.49x |
| P/B Ratio | 4.6x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 0.96% |
Alkem Laboratories has a market capitalisation of Rs 65,779.88 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 30.49x, P/B at 4.6x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 180.45, book value per share of Rs 1196.51, dividend yield of 0.96%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.87x, median ROE of 11.7%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 30.49x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 4.6x |
| Benchmark Median P/B | 3.08x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.25% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 12.93% |
| Company Market Capitalisation | Rs 65,779.88 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
| Benchmark Average Market Cap | Rs 13,926.75 crore |
Alkem Laboratories operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The sector benchmark covers the same industry and includes 204 companies. Against that reference set, Alkem Laboratories Share Price sits on a company P/E of 30.49 versus a benchmark median of 32.87 and an average of 48.77. Its P/B of 4.6 is above the benchmark median of 3.08 and slightly above the benchmark average of 4.31. ROE at 18.29% is above the benchmark median of 11.7% and average of 10.25%, while ROCE at 21.28% is above the benchmark median of 13.46% and average of 12.93%. That combination of return metrics places the stock above the benchmark center on profitability, even as its valuation sits close to the upper side of the sector’s book-value comparison.
The benchmark market-cap distribution also gives context. The sector median market capitalisation is Rs 701.78 crore and the average is Rs 13,926.75 crore, which shows how far Alkem Laboratories stands above the typical company in the industry universe. Sector comparison is useful because it helps readers of Alkem Laboratories Share Price News see whether the current quote looks isolated or part of a broader healthcare pattern. Univest uses this benchmark view to keep the analysis grounded in numbers, not assumptions. For investors checking Alkem Laboratories Share Price Today, the sector message is straightforward: the company’s profitability metrics are stronger than the benchmark median, while the valuation picture deserves comparison with healthcare peers.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Among the peer set supplied, Alkem Laboratories Share Price sits at Rs 65,779.88 crore market capitalisation, which is below Sun Pharmaceutical Industries at Rs 440,397.93 crore, Divi’s Laboratories at Rs 248,664.42 crore and Torrent Pharmaceuticals at Rs 182,738.23 crore, but above Zydus Lifesciences at Rs 115,012.19 crore, Cipla at Rs 110,793.75 crore, Laurus Labs at Rs 105,644.55 crore, Aurobindo Pharma at Rs 99,828.06 crore, Lupin at Rs 98,069.81 crore, Dr. Reddy’s Laboratories at Rs 97,749.41 crore and Mankind Pharma at Rs 95,743.85 crore. On valuation, Alkem’s P/E of 30.49 is below several high-multiple peers such as Divi’s Laboratories, Torrent Pharmaceuticals and Laurus Labs, while its P/B of 4.6 is above Cipla, Aurobindo Pharma, Lupin and Dr. Reddy’s Laboratories, and close to Sun Pharmaceutical Industries. On returns, ROE of 18.29% and ROCE of 21.28% are strong versus many peers, though Lupin, Torrent Pharmaceuticals and Zydus Lifesciences post higher or similar levels in this group. This is the kind of cross-check Univest uses in Alkem Laboratories Share Price Today coverage.
Why Investors Are Watching Alkem Laboratories
- Alkem Laboratories Share Price fell 2.26% today, or Rs 124.10, from Rs 5,501.60 to Rs 5,377.50.
- The day’s range was Rs 5,340.65 to Rs 5,409.80, which frames the session’s price action.
- Turnover stood at Rs 0.59 crore for the session.
- P/E is 30.49, P/B is 4.6, ROE is 18.29% and ROCE is 21.28%.
- In the healthcare benchmark, the company’s ROE and ROCE are above the median levels of 11.7% and 13.46%.
About Alkem Laboratories
Alkem Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is part of the Large Cap category as supplied in the data. In Univest coverage, Alkem Laboratories Share Price is analysed using the exact market-cap, valuation and return figures provided for the session, along with the industry benchmark and peer set. That helps readers place today’s share price fall in a wider stock-news framework without relying on unsupported assumptions. The company continues to attract attention in Alkem Laboratories Stock News because the current quote can be compared directly with its sector and peer valuations.
Track Alkem Laboratories Share Price on Univest
Use Alkem Laboratories (ALKEM) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Alkem Laboratories Share Price on Univest for live updates, valuation ratios, shareholding pattern, 52-week levels and market insights. Univest also presents Alkem Laboratories Share Price Today alongside company financials, sector context and peer comparisons so that the day’s move can be reviewed in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Alkem Laboratories Share Price fall today?
Ans. The supplied data confirms that Alkem Laboratories Share Price fell 2.26% today, but it does not establish a company-specific catalyst. The session close was Rs 5,377.50 versus a previous close of Rs 5,501.60.
What is Alkem Laboratories Share Price today?
Ans. Alkem Laboratories Share Price Today is Rs 5,377.50. The stock moved between Rs 5,340.65 and Rs 5,409.80 during the session, after opening at Rs 5,409.80 and finishing below the previous close.
How much did Alkem Laboratories share price decline?
Ans. Alkem Laboratories Share Price declined Rs 124.10 in the session. In percentage terms, the fall was 2.26% from the previous close of Rs 5,501.60, according to the supplied market data.
Is Alkem Laboratories a Large Cap company?
Ans. Yes, the supplied market-cap category is Large Cap. The company’s market capitalisation is Rs 65,779.88 crore, which places the stock well above the sector median market-cap level in the supplied benchmark set.
How does Alkem Laboratories compare with healthcare peers?
Ans. Alkem Laboratories has a P/E of 30.49, P/B of 4.6, ROE of 18.29% and ROCE of 21.28%. In the supplied peer set, it sits below some larger pharmaceutical names on market cap and above several on return ratios.
What do Alkem Laboratories fundamentals show?
Ans. The supplied fundamentals show EPS of Rs 180.45, book value of Rs 1,196.51 and dividend yield of 0.96%, alongside profitability ratios that are above benchmark medians. These figures give context to the current Alkem Laboratories Share Price.
